SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allogene Therapeutics, Inc. – ALLO
NEW YORK, Oct. 15, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Allogene Therapeutics, Inc. (“Allogene” or the “Company”) (NASDAQ: ALLO). Such investors are advised to contact Robert S. Willoughby at [email protected]…
